Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Serve Robotics (SERV) PT Lowered to $16 at Cantor Fitzgerald on Lower Robot Deliveries in FY26
-
Cantor Fitzgerald Starts Tenax Therapeutics (TENX) at Overweight
-
Cantor Fitzgerald on NVIDIA (NVDA): 'we believe risk is unbelievably favorable at this point in time'
-
Cantor Fitzgerald Starts Healios KK (4593:JP) at Overweight
-
CytomX announces $250 million public offering of stock and warrants
-
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Merlin completes SPAC merger, begins trading on NASDAQ
-
Merlin and Inflection Point Acquisition Corp. IV Announce Closing of Business Combination
-
Guardian Metal Resources PLC Announces Launch of Roadshow for US Initial Public Offering
-
Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)
-
Abra to go public via $750 million SPAC merger with New Providence
-
Cantor Fitzgerald Reiterates Overweight Rating on Broadstone Net Lease (BNL)
-
Abra, a Digital Asset Wealth Management Platform, to Become a Public Company via Business Combination With New Providence Acquisition Corp. III
-
INVESTOR ALERT: Investigation of M3-Brigade Acquisition V Corp. (MBAV) for Breaches of Fiduciary Duty and Self-Dealing in Connection with Proposed Business Combination with Sponsor-Controlled Affiliat
-
Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald After CEO Meet
-
KLA Corporation (KLAC) Reiterated at Overweight by Cantor Fitzgerald; A 'Top Pick'
-
Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald After Q4 Result
-
Korro Bio (KRRO) PT Raised to $22 at Cantor Fitzgerald on UCD Potential
-
Health Catalyst Inc. (HCAT) PT Lowered to $3 at Cantor Fitzgerald; No Turnaround Yet
-
Corvus Pharmaceuticals (CRVS) Reiterated at Overweight by Cantor Fitzgerald
-
Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results
-
SentinelOne (S) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Codexis, Inc. (CDXS) Following Q4 Print
-
Cantor Fitzgerald Reiterates Neutral Rating on Fortinet (FTNT), Notes Solid Customer Feedback
-
Cantor Fitzgerald Reiterates Overweight Rating on Compass Therapeutics (CMPX) Ahead of PFS/OS Readout
-
United Therapeutics Corp. (UTHR) PT Raised to $625 at Cantor Fitzgerald on IPF Potential
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA) Ahead of GTC Event
-
Agios Pharma (AGIO): 'Aqvesme's opportunity in thalassemia reason enough to own the stock,' says analyst
-
Cantor Fitzgerald Assumes Anteris Technologies Global (AVR) at Overweight, PT $15
-
AIR hires former Barclays analyst as VP of investor relations
-
AIR Appoints Gaurav Jain as Vice President, Investor Relations and Corporate Strategy
-
Zephyr Releases PSN Top Guns Managers of the Decade List for 2025 recognizing exceptional performance in separate accounts, managed accounts, and managed ETF strategies over a 10-year period
-
Aldabra 4 Liquidity Opportunity Vehicle, Inc. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on or About March 16, 2026
-
Artiva Biotherapeutics (ARTV) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results
-
Skye Bioscience (SKYE) Reiterated at Neutral by Cantor Fitzgerald After Model Updates
-
DOMO (DOMO) PT Lowered to $8 at Cantor Fitzgerald on Overall Software Multiples
-
Oracle (ORCL) Reiterated at Overweight by Cantor Fitzgerald on AI-Driven Momentum
-
Fiserv (FISV) Reiterated at Neutral by Cantor Fitzgerald After Company Commentary
-
Kodiak AI (KDK) Reiterated at Overweight by Cantor Fitzgerald: Bullish on Driverless Trucks
-
Cantor Fitzgerald Starts Satellos Bioscience Inc. (MSLE) at Overweight
-
America First Refining Secures Landmark 20-Year Offtake Agreement and Capital Investment to Construct First New U.S. Refinery in 50 years.
-
Ur-Energy Updates Lost Creek Property Technical Report Summary Estimating an Extended Mine Life and Increase in Net Cash Flow
-
Cantor Fitzgerald Reiterates Overweight Rating on Septerna Inc (SEPN)
-
Neurocrine Bio. (NBIX) PT Raised to $195 at Cantor Fitzgerald on Ingrezza Outlook
-
Cantor Fitzgerald Reiterates Overweight Rating on LifeMD Inc (LFMD) on Momentum Across Offering
-
3D Systems (DDD) PT Raised to $5 at Cantor Fitzgerald Following 'Respectable' Q4 Results
-
Beta Technologies (BETA) PT Lowered to $38 at Cantor Fitzgerald as 'Conservative on NT Ramp Up'
-
Cantor Fitzgerald Starts EMCOR Group (EME) at Overweight
-
Cantor Fitzgerald Starts Dycom Industries (DY) at Overweight
-
Faraday Future to Participate in Cantor’s 2nd Annual Global Technology & Industrial Growth Conference in New York City on March 10-11, 2026

